APERÇU CARTOGRAPHIQUE
| ESSAI CLINIQUE | INSTITUTION | TRAITEMENT OFFERT |
|---|---|---|
|
(EN) A Phase 2 Study of Blinatumomab in Combination With Nivolumab, a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged ? 1 to < 31 Years Old With First Relapse
COG-AALL1821 Interruption temporaire |
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE |
|
|
(EN) Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in
Golden Gate Study Actif en recrutement |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX |
|